Below are current research studies enrolling patients with Vascular Ehlers-Danlos Syndrome that provide key information about different factors for someone who has VEDS.
The DiSCOVER Trial: Decentralized Study Evaluating Celiprolol on VEDS-Related Events
Acer Therapeutics is conducting a clinical trial in the U.S. to evaluate the efficacy and safety of an investigational drug known as celiprolol for the treatment of vascular Ehlers-Danlos Syndrome (VEDS).
Acer Therapeutics is actively seeking potential participants with a confirmed diagnosis of VEDS caused by a COL3A1 mutation who are interested in participating in this investigational trial.
To pre-qualify for this clinical research study, you must meet the following criteria:
1. Must be greater than or equal to 15 years old
2. Willing to obtain a magnetic resonance angiogram (MRA) image
3. During screening, must have a genetic test performed, via a saliva sample, to confirm the presence of the COL3A1 mutation which will confirm a VEDS diagnosis; you will need a positive test result.
4. Must be able and willing to discontinue use of beta blockers under the care of your primary physician
5. Should not have had an arterial rupture or dissection, uterine rupture, and/or intestinal rupture within the last 6 months
6. Must be willing to complete all study procedures
Please note this is a summary of the main criteria to assess pre-eligibility and is not an exhaustive list. To learn more about the DiSCOVER trial, visit https://discoverceliprolol.com/
Pregnancy Among Families with VEDS
Dr. Morris’ team at Texas Children’s Hospital and Baylor College of Medicine have a new study looking at pregnancy among families with VEDS. The purpose of the study is collect more information to improve prenatal recommendations for families with VEDS and improve care during pregnancy.
People with a history of pregnancy who have a child with VEDS are eligible to enroll, regardless of whether they themselves have VEDS. Adults who have VEDS but do not have children are also eligible to enroll.
To participate, staff would ask families to sign a consent form and review a survey together over Zoom/phone. The survey should take about 20-30 minutes to complete. No travel is necessary. For more information, contact Dr. Morris’ coordinator, Sara Stephens, at 832-826-5613 or firstname.lastname@example.org.
NIGMS Repository Sample Requests for VEDS, LDS, and Marfan Syndrome
The NIGMS (National Institute of General Medical Sciences) Repository, housed at the Coriell Institute, is a research biobank that collects blood and/or tissue samples from individuals with genetic diseases and makes them into cell lines and DNA for scientists to use in biomedical research. Loeys-Dietz syndrome (LDS), Vascular Ehlers-Danlos syndrome (VEDS), and Marfan syndrome were recently listed on the American College of Medical Genetics and Genomics list of actionable conditions for increased research.
Coriell is now accepting blood (for lymphoblasts) and skin biopsy (for fibroblasts) samples from individuals with LDS, VEDS, and Marfan syndrome as well as their family members and relatives from domestic and international locations around the world.
Donors will receive a sample collection kit, instructions, and all necessary materials for collecting samples and returning the kit free of charge. Sample donors are required to submit supporting clinical data (e.g., genetic test results, medical records, physician summary records) that describes the diagnosis.
To submit a sample to the NIGMS Repository, email NIGMS@CORIELL.ORG with the following information:
The requested number of blood and skin biopsy collection kits for your family member(s)
Full name and age (for children) of each family member who will donate samples
The name, address, and phone number of the person or clinician to whom the collection kit(s) should be shipped.
Coriell does not conduct its own research but provides the materials for scientists around the world to perform research on genetic disorders. Also, Coriell does not provide donors with any results regarding their genetic disease nor information on their sample itself. For more information about Coriell and the sample donation process visit https://www.coriell.org/1/NIGMS/Affected-Families-Donate-Here/Donor-Portal-Home
Vascular Ehlers-Danlos Syndrome (VEDS) Research Collaborative Study
The VEDS Collaborative is dedicated to supporting the Vascular Ehlers-Danlos syndrome community in driving patient-centered outcomes research (PCOR) to improve the management of VEDS and increase the quality of life for people impacted by VEDS.
As part of the VEDS Collaborative, the University of Washington is conducting a natural history study to define the contribution of known VEDS gene mutations to VEDS complications and outcomes. The researchers are seeking individuals of any age with molecular confirmation of Vascular Ehlers-Danlos Syndrome (i.e., diagnosis through genetic testing results or skin biopsy results) who are willing to share their medical records and radiologic imaging to support a natural history study where the course of VEDS can be followed.
The hope is that this work will lead to treatment guidelines based on the underlying gene mutation and the discovery and/or creation of novel medical practices, diagnostic tools, protective therapies and medicines for the future that will prevent and/or cure the complications of VEDS.
More information about the study is available online. If you are interested in taking part in the study or would like more information, please contact the study team at (206) 353-3076 or email@example.com.
Pregnancy and Cardiac Disease Research
Researchers at the University of Texas Health Science Center at Houston are participating in the Registry on Pregnancy and Cardiac Disease (ROPAC), a worldwide project of the European Society of Cardiology. They are currently enrolling any women who became pregnant any time after December 2017 and who have, or have had, one of the following heart or blood vessel problems:
•Heart valve replacement surgery
•VEDS, Marfan syndrome, Loeys-Dietz syndrome, or another condition that can cause aortic aneurysms or dissections
If you meet these criteria, you may be eligible for the study. Enrollment takes only minutes and your contribution will provide lasting benefits to other women who have potentially fatal conditions. If you would like additional information or if you would like to enroll, please call the ROPAC study team at 713-500-6704.
Cardiac MRI Flow Characterization for Aortic Aneurysms
Aortic aneurysm surgery is often used to treat people with Marfan syndrome and other conditions that enlarge (dilate) the aorta. Aneurysm surgery can be life-saving, but some people can again develop aortic enlargement late after initial surgery.
This research will use new imaging (magnetic resonance) techniques to examine impact of surgical grafting on aortic shape and blood flow. Participation in this study involves an MRI exam before your aortic graft surgery. When/if you undergo surgery, we will ask to use aortic tissue obtained (that would otherwise be discarded) to compare MRI findings to actual tissue features. After your surgery, we will ask you to return for another MRI about six months following your procedure.
MRI exams will take place at Weill Cornell Medical College in New York City. Our research team will work with you to schedule your study visits on days and times that are convenient for you. If not ordered for clinical purposes by your doctor, your MRI exams will be paid for by the research study and will be of no cost to you.
You may be eligible for this study if you:
•Have Marfan syndrome, VEDS or another condition in which your aorta is dilated (enlarged)
•Are being considered for or have undergone aortic graft surgery
You aren’t eligible if you:
•Can’t have an MRI because you have a pacemaker, defibrillator, or other contraindication
•Are very claustrophobic (have a fear of small spaces)
•Are pregnant (at time of MRI)
The Cornell research team includes leading investigators with expertise in cardiac imaging, cardiothoracic surgery, biomedical engineering, and clinical outcomes research. Dr. Jonathan Weinsaft (Director, Cornell Cardiac MRI program), the leader of this study, is an expert in the field of cardiac MRI and aortic imaging.
To learn more about this study, please contact the research team by e-mail at firstname.lastname@example.org or by phone at (212) 746-2627. Study team members are available to answer any questions you may have regarding research participation.
Evaluation of an Imaging Biomarker in Children and Young Adults with Aortopathy
Researchers at Texas Children’s Hospital and Baylor College of Medicine are doing a study entitled “Evaluation of an Imaging Biomarker in Children and Young Adults.” These investigators will measure and observe an imaging biomarker overtime which may help predict risk of dilation and changes in the aorta.
You can participate in the study if you:
•Have Loeys-Dietz Syndrome or Vascular Ehlers Danlos Syndrome
•Have undergone at least 1 either MRA or CTA that is available for review, AND that study was performed younger than age 50 years
•About 2-3 hours of study procedures at Texas Children’s Hospital.
•A blood test (taking around 1 tablespoon of blood)
•An EndoPAT Test (a blood pressure cuff will be inflated on your arm for 5 minutes and then released to measure how well the lining of your blood vessels widen and narrow)
•A Tonometry (measures pulse at your neck and groin to see how long it takes to travel from your heart to the leg)
•A consult to confirm your eligibility
•An echocardiogram of your heart and blood vessels
•Follow-up visits every two years to complete a 10-year follow-up period
•Alternatively, patients can enroll without the study visit and just have medical records review
•Your participation may help improve evidence based clinical guidelines for the management of different aortopathies.
•$13 compensation for parking for those who participate in person will be included in your participation.
To learn more, contact contact Sara Stephens, email@example.com, or 832-826-5613
Pregnancy in Connective Tissue Disorders Study
What: Dr. Melissa Russo, Dr. Jennifer Pardo Habashi, and their team at Johns Hopkins University are interested in obtaining more information on pregnancy outcomes in women with connective tissue disorders, including Vascular Ehlers Danlos Syndrome (VEDS), Marfan syndrome and Loeys-Dietz syndrome. Their project, entitled “Pregnancy in Connective Tissue Disorders,” features a questionnaire about pregnancy outcomes in women with these syndromes and their cardiovascular (heart-related) complications.
Who: Women with Marfan syndrome, Loeys-Dietz syndrome, or VEDS who have had pregnancies, as well as family members of women with Marfan syndrome, Loeys-Dietz, or VEDS who may have passed away during or post-pregnancy. It’s important to have information from women and family members with a range of experiences, from successful to complicated pregnancies.
The questionnaire: The questions ask how you got your diagnosis of a connective tissue disorder, your medications and imaging, and the management of the pregnancy in relation to your connective tissue disorder. The survey will take between 20-60 minutes depending on the number of pregnancies. It may be appropriate to have your medical history available while filling out the survey since you cannot save the survey for completion at another time.
Why: Your participation will help us learn about pregnancy in women with these syndromes, an area in which there is still very little information in the medical literature.
How: Here is the link to complete the “Pregnancy in Connective Tissue Disorders” Questionnaire: http://www.surveymonkey.com/s/CTDpregnancy. By completing and submitting the questionnaire, you are consenting to participating in the study. Additionally, if you are not a patient at Johns Hopkins, we will request that you provide the research team with copies of your medical records that verify your diagnosis and summary of medical care if you had a cardiovascular or obstetrical complication during a pregnancy. If you have questions and want to talk with a study team member prior to filling out the survey, please email (CTDpregnancy@jhmi.edu).
Thank you for your consideration and support in trying to make further inroads into the understanding of connective tissue disorders. JHM eIRB Study Number: NA_00086443
Exercise in Heritable Aortic and Vascular Diseases Study
As a cardiologist who specializes in heritable aortic and vascular diseases, I am frequently asked about what exercises may be safe and beneficial for patients who are living with aortic aneurysms or dissections. I discovered that there are no evidence-based guidelines to help answer these questions. The overall goal of this study is to determine how blood pressure responds to typical types of isometric and aerobic exercises in patients with heritable arterial diseases, including Marfan syndrome and vEDS. We know that sudden increases in blood pressure with exercise can trigger aortic dissections, but the frequency and severity of these problems are not understood. My research is designed to answer several questions: 1) How common are dangerous increases in blood pressure with moderate levels of exercise?; 2) Do certain activities pose a greater risk to vEDS patients and should be restricted?; 3) Can we develop tests to determine rational and safe limits to guide exercise recommendations for individual patients?; 4) Does the blood pressure response to exercise predict risks for aortic enlargement or dissection in unique ways that other tests may not detect?; 5) Can aortic stiffness be a useful biomarker to predict which patients will develop dissections in the future and guide therapies?; 6) How do blood pressure medications affect exercise risk? We will develop new guidelines for exercise and daily activities that promote the safety and well-being of all patients who are living with vascular diseases.
To participate in our study, you will need to come to Houston. To learn more about our study, please call Jacqueline Jennings at 713-500-6724 or email us at Siddharth.K.Prakash@uth.tmc.edu.
Genetic Testing Research Study
The Genomic Services Research Program (GSRP) is a study of people with “secondary results” from genetic testing. Secondary results are unexpected. They are not related to the reason the person had the genetic test but are shared because they may be very important to the person’s health. Most secondary results have to do with high risks for health problems that can be treated or prevented. Many of these results are related to cancer risk and heart conditions. If you think you have received a secondary result, you may be eligible to join this study.
The purpose of this study is to learn about how people react to their secondary result and the actions they take after learning this information. If you or a member of your family have been given a secondary result, please consider partnering with us on this research. Together we hope to understand the health impacts of secondary results on you and your family and discover ways to better support people like you.
What is involved in for people who join?
If you join the study, the first phase is a survey and phone interview. We will ask you about any changes you made to your healthcare based on the result. We will also ask if there were recommendations you did not follow and why. Finally, we will ask questions about sharing the result with your family members. Following the interview you may be invited to the second phase of the study, which could include extra testing for you and/or your family members at the NIH or in your area. Participating in this study and having testing done at the NIH is free. If we ask you to come to the NIH, and you live in the United States, we will pay for your travel and a hotel.
1. Must speak English or Spanish
2. Must have received a genetic testing result related to cancer risk or heart disease even though they were not having genetic testing to get information about this condition.
For more information, please visit: https://www.genome.gov/Current-NHGRI-Clinical-Studies/Genomic-Services-Research-Program
Learn more about participating in a study. If you are a researcher and have a current research study about Vascular Ehlers-Danlos Syndrome (VEDS) you would like listed on our website, see our guidelines and how-to here.
See current information on treatment and management of VEDS.